Journal for ImmunoTherapy of Cancer (Nov 2023)

510 ES008, a high affinity LILRB1 specific blocking antibody activates multiple immune cells to fight cancers

  • Rui Gao,
  • Chunnian Wang,
  • Dawei Sun,
  • Hongtao Lu,
  • Xiaofeng Niu,
  • Haixia Jiang,
  • Quan Qiu

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0510
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.